Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
AORT · against 467 other Healthcare companies of similar size
Ranked #287 of 468 · scores higher than 38% of peers
Bars: peers in each 10-point band of the valuation score44 peers with a valuation score of 40–49, including AORT · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | AORT | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 459 reported | -0.3% | 1.4% | 40% | 30% | |
| EBITDA yieldHigher is better · 472 reported | 4.3% | 4.3% | 49% | 50% | |
| Free cash flow yieldHigher is better · 203 reported | -0.8% | -1.6% | 53% | 20% | |
| Book yieldHigher is better · 464 reported | 38.6% | 40.7% | 48% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 12.9B HKD (≈$1.7B) | 99 | 83 | |
| 1 | 89.9B JPY (≈$611M) | 99 | 68 | |
| 1 | 226.3B JPY (≈$1.5B) | 99 | 77 | |
| 1 | 40.2B MXN (≈$2.2B) | 99 | 71 | |
| 283 | 8.8B CNY (≈$1.2B) | 41 | 54 | |
| 283 | 1.6B USD | 41 | 29 | |
| 283 | 2.1B USD | 41 | 61 | |
| 287 | 4.4B CNY (≈$618M) | 40 | 66 | |
| 287 | 1.2B USD | 40 | 42 | |
| 287 | 1.3B CHF (≈$1.5B) | 40 | 48 | |
| 290 | 4.3B CNY (≈$596M) | 39 | 56 | |
| 290 | 1.5B USD | 39 | 63 | |
| 290 | 1.6B USD | 39 | 43 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score